Evidence map›Paper›PMID 28336518›Full record

ArticleGut2017

BMP-9 interferes with liver regeneration and promotes liver fibrosis.

Katja Breitkopf-Heinlein, Christoph Meyer, Courtney König, Haristi Gaitantzi, Annalisa Addante, Maria Thomas, Eliza Wiercinska, Chen Cai, Qi Li, Fengqi Wan and 20 more

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Gut, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 11 institutions in 5 countries.

Katja Breitkopf-HeinleinDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Christoph MeyerDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Courtney KönigDivision of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.
Haristi GaitantziDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Annalisa AddanteDepartment of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University of Madrid, San Carlos Clinical Hospital Health Research Institute (IdISSC), Madrid, Spain.
Maria ThomasDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany.
Eliza WiercinskaGerman Red Cross Blood Service Baden-Württemberg-Hessen and Institute for Transfusion Medicine and Immunohaematology, Goethe University, Frankfurt, Germany.
Chen CaiDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Qi LiDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Fengqi WanDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Claus HellerbrandDepartment of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany.
Nektarios A ValousApplied Tumor Immunity Clinical Cooperation Unit, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
Maximilian HahnelUniversity Hospital of the Heinrich-Heine University, Duesseldorf, Germany.
Christian EhltingUniversity Hospital of the Heinrich-Heine University, Duesseldorf, Germany.
Johannes G BodeUniversity Hospital of the Heinrich-Heine University, Duesseldorf, Germany.
Stephanie Müller-BohlDivision Systems Biology of Signal Transduction, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ursula KlingmüllerDivision Systems Biology of Signal Transduction, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jutta AltenöderDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Iryna IlkavetsDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Marie-José GoumansDepartment of Molecular Cell Biology and Centre for Cancer Genomics, Leiden University Medical Center, Leiden, The Netherlands.
Lukas J A C HawinkelsDepartment of Molecular Cell Biology and Centre for Cancer Genomics, Leiden University Medical Center, Leiden, The Netherlands.
Se-Jin LeeJohns Hopkins University School of Medicine, Molecular Biology and Genetics, Baltimore, USA.
Matthias WielandDivision of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.
Carolin MoglerInstitute of Pathology, Technical University of Munich, München, Germany.
Matthias P EbertDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Blanca HerreraDepartment of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University of Madrid, San Carlos Clinical Hospital Health Research Institute (IdISSC), Madrid, Spain.
Hellmut AugustinDivision of Vascular Oncology and Metastasis, German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Heidelberg, Germany.
Aránzazu SánchezDepartment of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University of Madrid, San Carlos Clinical Hospital Health Research Institute (IdISSC), Madrid, Spain.
Steven DooleyDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Peter Ten DijkeDepartment of Molecular Cell Biology and Centre for Cancer Genomics, Leiden University Medical Center, Leiden, The Netherlands.
Heidelberg University · DEGerman Cancer Research Center · DEDüsseldorf University Hospital · DELeiden University Medical Center · NLUniversidad Complutense de Madrid · ESCapital Medical University · CNDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DEGoethe University Frankfurt · DEJohns Hopkins University · USTechnical University of Munich · DEUniversity Hospital Regensburg · DE

Funding

Characterization of Myostatin and GDF-11R01AR060636 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LEE, SE-JIN · 2010 to 2020
$3.7M
NIAMS NIH HHS R01 AR060636
6 · The paper itself

Abstract

objectiveBone morphogenetic protein (BMP)-9, a member of the transforming growth factor-β family of cytokines, is constitutively produced in the liver. Systemic levels act on many organs and tissues including bone and endothelium, but little is known about its hepatic functions in health and disease.

designLevels of BMP-9 and its receptors were analysed in primary liver cells. Direct effects of BMP-9 on hepatic stellate cells (HSCs) and hepatocytes were studied in vitro, and the role of BMP-9 was examined in acute and chronic liver injury models in mice.

resultsQuiescent and activated HSCs were identified as major BMP-9 producing liver cell type. BMP-9 stimulation of cultured hepatocytes inhibited proliferation, epithelial to mesenchymal transition and preserved expression of important metabolic enzymes such as cytochrome P450. Acute liver injury caused by partial hepatectomy or single injections of carbon tetrachloride (CCl

conclusionsConstitutive expression of low levels of BMP-9 stabilises hepatocyte function in the healthy liver. Upon HSC activation, endogenous BMP-9 levels increase in vitro and in vivo and high levels of BMP-9 cause enhanced damage upon acute or chronic injury.

Indexed as

Acute Lung InjuryAnimalsCell ProliferationCells, CulturedDisease Models, AnimalDown-RegulationEpithelial-Mesenchymal TransitionGrowth Differentiation Factor 2HepatectomyHepatic Stellate CellsHepatocytesLipopolysaccharidesLiver CirrhosisLiver RegenerationMaleMiceGrowth Differentiation Factor 2LipopolysaccharidesCYTOKINESGROWTH FACTORSHEPATIC FIBROSISHEPATIC STELLATE CELLHEPATOCYTE

Identifiers

PMID28336518
OpenAlexW2603787753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.